Experts in Oncology Drug Development Consulting

Contact Us

Welcome to
Ailse Oncology Ltd

Ailse Oncology Ltd has translational and clinical development expertise across a wide range of solid tumours and haematological malignancies and works with the pharmaceutical/ biotechnology industry, medical charities and academia in Europe, North America and Asia.

Managing Director: Glen Clack MD MB BS FFPM

Honorary Professor of Translational Medicine, Department of Oncology and Metabolism, Faculty of Medicine, University of Sheffield


Strategic clinical development plans
Participation in scientific advisory boards, and data monitoring and safety review committees
Translational/experimental cancer medicine strategy
Key opinion leader development
Interactions with regulatory agencies on behalf of clients
Clinical study protocol development

Current Clients

Aptus Clinical Ltd

Alderley Park, Cheshire, SK10 4TG, United Kingdom


Herestraat 49, Box 913, B-3000 Leuven, Belgium

Cumulus Oncology

1 Summerhall Place, Edinburgh, EH9 1PL, United Kingdom

Evgen Pharma

146 Brownlow Hill, Liverpool, L3 5RF, United Kingdom

Grey Wolf Therapeutics

Clarendon Business Centre, 57 Woodstock Road, Oxford, OX2 6HJ, United Kingdom

Inventiva Pharma

50 rue de Dijon, 21121 Daix, France


Current and Previous Roles of Glen Clack

Translational and early clinical development of anti-cancer agents, from lead optimisation to clinical proof of concept in solid and haematological malignancies; both as monotherapy and combination with other anti-cancer treatments including small molecules, chemotherapy, radiotherapy and immune oncology agents.

The relevant biological effect areas of these compounds have included hormone manipulation, invasion, DNA damage repair, immune modulation, angiogenesis, MTOR/PI3K/AKT and MET pathways, anti-sense oligonucleotide, and tumour genetic drivers.

This includes the overall clinical, scientific & value content, risk benefit assessment and delivery of the medical science components to the projects to time & quality, the translational and clinical strategy, ethical and scientific integrity of the plans, studies and the product, and the risk management plan.


Chief Medical Officer

Modulus Oncology Ltd.


Oncology Drug Development Advisor

Cumulus Oncology Ltd.


Managing Director

Ailse Oncology Ltd., Lyme Green, Cheshire

View More

Contact Us

Please fill in the contact form and we will get back to you as soon as possible.

Ailse Oncology Ltd
First Floor, Merchant Exchange
Waters Green
Cheshire SK11 6JX
United Kingdom

+44 7765 898619

IPSE member

We use cookies to personalise and enhance your experience on our site and improve the delivery of ads to you. Visit our Cookie Policy to learn more. By clicking 'accept', you agree to our use of cookies.